| 2:00 - 2:05 |
Introduction |
Mike Paulden |
| 2:05 - 2:15 |
Summary of policy background and scope of working group’s remit |
Mike Paulden |
| 2:15 - 2:30 |
Topic 1: Options for determining what drugs fall into ‘Category 1 |
Group discussion |
| 2:30 - 2:45 |
Topic 2: Application of supply-side cost effectiveness thresholds in setting ceiling prices for Category 1 drugs |
Group discussion |
| 2:45 - 3:00 |
Topic 3: Drugs with multiple indications |
Group discussion |
| 3:00 - 3:15 |
Topic 4: Accounting for uncertainty |
Group discussion |
| 3:15 - 3:30 |
Topic 5: Perspectives |
Group discussion |
| 3:30 - 3:45 |
Topic 6: Application of the market size factor in setting ceiling prices |
Group discussion |
| 3:45 - 4:00 |
Open discussion and Closing |
Mike Paulden |